Literature DB >> 1591524

Development and validation of a multi-dimensional instrument for assessing outcome of treatment among opiate users: the Opiate Treatment Index.

S Darke1, W Hall, A Wodak, N Heather, J Ward.   

Abstract

This article presents a new instrument with which to assess the effects of opiate treatment. The Opiate Treatment Index (OTI) is multi-dimensional in structure, with scales measuring six independently measured outcome domains: drug use; HIV risk-taking behaviour; social functioning; criminality; health; and psychological adjustment. Psychometric properties of the Index are excellent, suggesting that the OTI is a relatively quick, efficient means of obtaining reliable and valid data on opiate users undergoing treatment over a range of relevant outcome domains.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1591524     DOI： 10.1111/j.1360-0443.1992.tb02719.x

Source DB:  PubMed          Journal:  Br J Addict        ISSN： 0952-0481


  70 in total

1.  Effect of pegylated interferon-α-2a treatment on mental health during recent hepatitis C virus infection.

Authors:  Maryam Alavi; Jason Grebely; Gail V Matthews; Kathy Petoumenos; Barbara Yeung; Carolyn Day; Andrew R Lloyd; Ingrid Van Beek; John M Kaldor; Margaret Hellard; Gregory J Dore; Paul S Haber
Journal:  J Gastroenterol Hepatol       Date:  2012-05       Impact factor: 4.029

2.  Attempted suicide among injecting and noninjecting cocaine users in Sydney, Australia.

Authors:  Shane Darke; Sharlene Kaye
Journal:  J Urban Health       Date:  2004-09       Impact factor: 3.671

3.  Self-report of Longitudinal Substance Use: A Comparison of the UCLA Natural History Interview and the Addiction Severity Index.

Authors:  Debra A Murphy; Yih-Ing Hser; David Huang; Mary-Lynn Brecht; Diane M Herbeck
Journal:  J Drug Issues       Date:  2010-03

4.  Patterns of nonfatal heroin overdose over a 3-year period: findings from the Australian treatment outcome study.

Authors:  Shane Darke; Anna Williamson; Joanne Ross; Katherine L Mills; Alys Havard; Maree Teesson
Journal:  J Urban Health       Date:  2007-03       Impact factor: 3.671

5.  Comparing opium tincture and methadone for medication-assisted treatment of patients with opioid use disorder: Protocol for a multicenter parallel group noninferiority double-blind randomized controlled trial.

Authors:  Mohammadali Nikoo; Ehsan Moazen-Zadeh; Nooshin Nikoo; Sanam Javidanbardan; Alireza Kazemi; Fiona Choi; Marc Vogel; Ali Gholami; Saeed Tavakoli; Reza Givaki; Majid Jazani; Fatemeh Mohammadian; Nader Markazi Moghaddam; Nasser Goudarzi; Christian Schutz; Kerry Jang; Shahin Akhondzadeh; Michael Krausz
Journal:  Int J Methods Psychiatr Res       Date:  2019-02-04       Impact factor: 4.035

6.  Economic Evaluation of Mental Health Interventions: A Guide to Costing Approaches.

Authors:  James Shearer; Paul McCrone; Renee Romeo
Journal:  Pharmacoeconomics       Date:  2016-07       Impact factor: 4.981

7.  Effective treatment of injecting drug users with recently acquired hepatitis C virus infection.

Authors:  Gregory J Dore; Margaret Hellard; Gail V Matthews; Jason Grebely; Paul S Haber; Kathy Petoumenos; Barbara Yeung; Philippa Marks; Ingrid van Beek; Geoffrey McCaughan; Peter White; Rosemary French; William Rawlinson; Andrew R Lloyd; John M Kaldor
Journal:  Gastroenterology       Date:  2009-09-24       Impact factor: 22.682

8.  A double-blind randomized controlled trial of oxytocin nasal spray and social cognition training for young people with early psychosis.

Authors:  Cristina Cacciotti-Saija; Robyn Langdon; Philip B Ward; Ian B Hickie; Elizabeth M Scott; Sharon L Naismith; Loretta Moore; Gail A Alvares; Marie Antoinette Redoblado Hodge; Adam J Guastella
Journal:  Schizophr Bull       Date:  2014-06-23       Impact factor: 9.306

9.  Factors associated with uptake of treatment for recent hepatitis C virus infection in a predominantly injecting drug user cohort: The ATAHC Study.

Authors:  J Grebely; K Petoumenos; G V Matthews; P Haber; P Marks; A R Lloyd; J M Kaldor; G J Dore; M Hellard
Journal:  Drug Alcohol Depend       Date:  2010-03-01       Impact factor: 4.492

10.  Screening for personality disorder with the Standardised Assessment of Personality: Abbreviated Scale (SAPAS): further evidence of concurrent validity.

Authors:  Morten Hesse; Paul Moran
Journal:  BMC Psychiatry       Date:  2010-01-28       Impact factor: 3.630
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.